Cart
sales@molnova.com
LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))
CAS No. ——
LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))( —— )
Catalog No. M19315 CAS No. ——
LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 298 | Get Quote |
|
| 10MG | 470 | Get Quote |
|
| 25MG | 658 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))
-
NoteResearch use only, not for human use.
-
Brief DescriptionLMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
-
DescriptionLMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetIGF-1R
-
RecptorLMPTP-A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight481.07
-
Molecular FormulaC28H37ClN4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.CCN(CC)C(=O)c1ccc(cc1)c3nc2ccccc2c(c3)NCCCN4CCCCC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stanford SM1, et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol. 2017 Jun;13(6):624-632.
molnova catalog
related products
-
IGF-I 24-41
IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).
-
Insulin efsitora alf...
Insulin efsitora alfa (LY-3209590) is a selective insulin receptor (IR) agonist and fusion protein that combines a novel single-chain insulin variant with the structural domain of human IgG Fc for the study of type 2 diabetes.
-
KW-2450 free base
KW-2450 free base is an orally bioavailable inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (IR) tyrosine kinases with potential antineoplastic activity.
